Sorrento Therapeutics, Inc.
SRNE · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $70 | $38 | $24 | $71 |
| Short-Term Investments | $11 | $13 | $26 | $47 |
| Receivables | $33 | $27 | $24 | $24 |
| Inventory | $10 | $11 | $10 | $18 |
| Other Curr. Assets | $10 | $13 | $12 | $17 |
| Total Curr. Assets | $133 | $101 | $96 | $177 |
| Property Plant & Equip (Net) | $107 | $140 | $138 | $129 |
| Goodwill | $80 | $80 | $80 | $80 |
| Intangibles | $122 | $124 | $137 | $171 |
| Long-Term Investments | $12 | $12 | $17 | $56 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $3 | $4 | $3 |
| Total NC Assets | $324 | $359 | $376 | $439 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $457 | $460 | $473 | $616 |
| Liabilities | – | – | – | – |
| Payables | $19 | $15 | $48 | $38 |
| Short-Term Debt | $133 | $78 | $30 | $80 |
| Tax Payable | $13 | $12 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $0 |
| Other Curr. Liab. | $100 | $61 | $250 | $84 |
| Total Curr. Liab. | $265 | $166 | $328 | $202 |
| LT Debt | $74 | $106 | $104 | $102 |
| Deferred Rev, NC | $1 | $1 | $7 | $117 |
| Deferred Tax Liab, NC | $0 | $0 | $1 | $2 |
| Other NC Liab. | $314 | $315 | $55 | $63 |
| Total NC Liab. | $390 | $422 | $167 | $283 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $65 | $99 | $99 | $98 |
| Total Liabilities | $655 | $587 | $495 | $485 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$2,194 | -$2,099 | -$1,959 | -$1,736 |
| AOCI | $2 | $2 | $2 | $0 |
| Other Equity | $1,987 | $1,972 | $1,939 | $1,867 |
| Total Equity | -$205 | -$125 | -$19 | $132 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $7 | -$2 | -$3 | -$2 |
| Total Liab. & Tot. Equity | $457 | $460 | $473 | $616 |
| Net Debt | $138 | $146 | $111 | $111 |